260 related articles for article (PubMed ID: 26418031)
1. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways.
Leve F; Peres-Moreira RJ; Binato R; Abdelhay E; Morgado-Díaz JA
PLoS One; 2015; 10(9):e0139094. PubMed ID: 26418031
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.
Yang M; Zhong WW; Srivastava N; Slavin A; Yang J; Hoey T; An S
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6027-32. PubMed ID: 15837931
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin, cancer, and G proteins: not just for frizzleds anymore.
Malbon CC
Sci STKE; 2005 Jul; 2005(292):pe35. PubMed ID: 16014605
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
Hurst JH; Hooks SB
Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
Ryu JM; Han HJ
Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
[TBL] [Abstract][Full Text] [Related]
11. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells.
Tveteraas IH; Aasrum M; Brusevold IJ; Ødegård J; Christoffersen T; Sandnes D
Tumour Biol; 2016 Feb; 37(2):2519-26. PubMed ID: 26386720
[TBL] [Abstract][Full Text] [Related]
13. The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.
Jeong KJ; Park SY; Cho KH; Sohn JS; Lee J; Kim YK; Kang J; Park CG; Han JW; Lee HY
Oncogene; 2012 Sep; 31(39):4279-89. PubMed ID: 22249252
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5.
Zhang H; Bialkowska A; Rusovici R; Chanchevalap S; Shim H; Katz JP; Yang VW; Yun CC
J Biol Chem; 2007 May; 282(21):15541-9. PubMed ID: 17430902
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro.
Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T
Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844
[TBL] [Abstract][Full Text] [Related]
16. Wnt-signaling mediates the anti-adipogenic action of lysophosphatidic acid through cross talking with the Rho/Rho associated kinase (ROCK) pathway.
Li L; Tam L; Liu L; Jin T; Ng DS
Biochem Cell Biol; 2011 Dec; 89(6):515-21. PubMed ID: 21999426
[TBL] [Abstract][Full Text] [Related]
17. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
18. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
19. LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cells.
Kim JH; Adelstein RS
J Cell Physiol; 2011 Nov; 226(11):2881-93. PubMed ID: 21302283
[TBL] [Abstract][Full Text] [Related]
20. Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway.
Lu YM; Chen W; Zhu JS; Chen WX; Chen NW
Mol Med Rep; 2016 Mar; 13(3):2235-40. PubMed ID: 26795301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
